Exscientia Ltd (Exscientia) is a company that automates the drug discovery and design process, leveraging artificial intelligence (AI) and big data technologies. Its AI-driven platform, Centaur AI, enables researchers to design numerous target specific compounds and pre-assess their potency, and Experiment AI provides successful experimental outcomes.
This report provides insights into Exscientia Ltd., including an overview of the company and its product offering, detailed coverage of its business model and operations, information on its funding and partnerships, and biographies of its senior management.
This report provides insights into Exscientia Ltd., including an overview of the company and its product offering, detailed coverage of its business model and operations, information on its funding and partnerships, and biographies of its senior management.
Reasons to Buy
- Gain insights into Exscientia Ltd. business operations.
- Gain insights into its partnerships and funding.
- Gain an understanding of its technology focus.
Table of Contents
- Company Overview
- Technology Focus
- Product Overview
- Partnership
- Funding
- Key Employees
- Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- MD Anderson
- Evotec
- Sanofi SA
- ARUK-ODDI
- Blue Oak Pharmaceuticals
- Huadong Medicine
- Bayer
- Celgene
- F. Hoffmann-La Roche AG
